The TRAIN-HEART consortium, funded by the European Commission (2019-2023), is made up to train a league of 15 promising fellows that harness novel insights in the pathogenesis of ischemic heart failure, study the therapeutic potential of existing RNA therapeutics and improve its efficacy by the design of novel drug delivery systems.
TRAIN-HEART brings together leading academic teams and (biotech) companies covering various disciplines ranging from fundamental research to clinical pharmacology and gene therapy to drug delivery applications, have teamed up in the European Union.
The TRAIN-HEART network aims to gain viable insight in the pathogenesis of ischemic heart failure which will serve as a basis for drug discovery and drug delivery efforts that aim to therapeutically target specific molecules and mechanisms within cardiomyocytes for the treatment of ischemic heart failure.
If you have any questions you can fill in the form or mail us directly: info@train-heart.eu.
News
Presenter: Professor Mauro Giacca
Title: High throughput screening
Date: 10 December 2020, 16.00-17.00h.
The King's British Heart Foundation (BHF) Centre of Research Excellence will be hosting a number of workshops as part of its Technology Workshop series. These workshops are intended mainly for postgraduate students but also for interested postdoctoral researchers.
Attendees will be introduced to the Centre's (King's College London in this case) cutting-edge research techniques and facilities, which would have potential applications in many cardiovascular research projects.
More information and the access link (registration not needed) can be found HERE .
Fri, 04 December
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement no. 813716.
Copyright © 2020
